Cargando…
Tocilizumab in systemic sclerosis treatment: a case report
INTRODUCTION: In the United States, tocilizumab was approved for the treatment of scleroderma and scleroderma-related interstitial lung disease because it inhibited the decrease in forced expiratory volume, so scleroderma treatment is entering a new era. CASE PRESENTATION: A 44-year-old female patie...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473287/ https://www.ncbi.nlm.nih.gov/pubmed/37663690 http://dx.doi.org/10.1097/MS9.0000000000000969 |